Skip to main content
logo
Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
5.87
+0.06 (1.03%)
At close: Aug 5, 2026, 4:00 PM EDT
5.87
0.00 (0.06%)
After-hours: Aug 5, 2026, 7:49 PM EDT

Verastem Revenue

Verastem had revenue of $18.67M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $49.59M, up 395.85% year-over-year. In the year 2025, Verastem had annual revenue of $30.91M with 209.14% growth.

Revenue (ttm)
$49.59M
Revenue Growth
+395.85%
P/S Ratio
10.40
Revenue / Employee
$486,127
Employees
102
Market Cap
515.82M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202530.91M20.91M209.14%
Dec 31, 202410.00M--
Dec 31, 2023---
Dec 31, 20222.60M543.00K26.45%
Dec 31, 20212.05M-86.46M-97.68%
Dec 31, 202088.52M71.06M407.08%
Dec 31, 201917.46M-9.26M-34.67%
Dec 31, 201826.72M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Valneva SE180.25M
Autolus Therapeutics92.62M
Arvinas89.40M
Assembly Biosciences71.10M
Adlai Nortye5.00M
Prime Medicine4.03M
Silence Therapeutics839.00K
Artiva Biotherapeutics251.00K
Revenue Rankings

VSTM News

More News